PET/CT: Radiation Therapy Planning in Head and Neck Cancer.

Szczegóły
Abstrakt

Tytuł:: PET/CT: Radiation Therapy Planning in Head and Neck Cancer.
Autorzy:: Eraj S; Department of Radiation Oncology, University of Texas Southwestern Medical Center, 2280 Inwood Drive, Dallas, TX 75390, USA.
Sher DJ; Department of Radiation Oncology, University of Texas Southwestern Medical Center, 2280 Inwood Drive, Dallas, TX 75390, USA. Electronic address: .
Źródło:: PET clinics [PET Clin] 2022 Apr; Vol. 17 (2), pp. 297-305. Date of Electronic Publication: 2022 Mar 04.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Original Publication: Philadelphia : Elsevier Saunders, c2006-
MeSH Terms:: Head and Neck Neoplasms*/diagnostic imaging
Head and Neck Neoplasms*/radiotherapy
Positron Emission Tomography Computed Tomography*/methods
Fluorodeoxyglucose F18 ; Humans ; Positron-Emission Tomography/methods ; Radiopharmaceuticals ; Radiotherapy Planning, Computer-Assisted/methods ; Tomography, X-Ray Computed
Contributed Indexing:: Keywords: Adaptive radiotherapy; PET/CT; Radiation planning
Substance Nomenclature:: 0 (Radiopharmaceuticals)
0Z5B2CJX4D (Fluorodeoxyglucose F18)
Entry Date(s):: Date Created: 20220308 Date Completed: 20220331 Latest Revision: 20220401
Update Code:: 20240104
DOI:: 10.1016/j.cpet.2021.12.007
PMID:: 35256302
: Czasopismo naukowe

Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) has an integral role in modern radiotherapy planning for most patients with head and neck malignancies. Fluorine-18-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) should guide standard target delineation and has emerging roles in dose and volume modification for escalation/de-escalation and adaptive radiotherapy. This article discusses the integration of PET/CT into radiotherapy planning.
Competing Interests: Disclosure The authors have nothing to disclose.
(Copyright © 2021 Elsevier Inc. All rights reserved.)

Informacja